PORTABLE WIRELESS EPILEPSY EEG MONITOR
CLEVELAND MEDICAL DEVICES, INC. · Department of Health and Human Services
Phase II1997$750,000
N/A
Public Market Intelligence
SBIR/STTR Research Awards
Explore federally funded small business innovation research, technology awards, participating companies, and agency investments.
Company count, total reported award value are not available for this view.
- View Award
- View Award
PASSIVE SENSOR ALTITUDE AND TERRAIN AWARENESS SYSTEM
CHARLES RIVER ANALYTICS, INC. · Department of Defense
Phase II1992$497,806
THE PRIMARY OBJECTIVE OF THE PHASE I STUDY IS TO EVALUATE THE FEASIBILITY OF DEVELOPING A PASSIVE OPTICAL SENSOR ALTITUDE AND TERRAIN AWARENESS SYSTEM (ATAS). THE BASIC TECHNIQUE PROPOSED FOR STUDY MAKES USE OF THE OPTI…
- View Award
Parallel Assays for Anti-Ro Peptide Diagnostics
JK AUTOIMMUNITY, INC. · Department of Health and Human Services
Phase I2003$175,000
DESCRIPTION (provided by the applicant): Diagnosis of rheumatic diseases is inefficient, time consuming, and frustrating. Indeed, many patients suffer unnecessarily. We wish to develop a parallel assay system for the se…
- View Award
PERCUTANEOUS ELECTRODES FOR INTRAMUSCULAR STIMULATION
EIC LABORATORIES, INC. · Department of Health and Human Services
Phase I1985$49,917
N/A
- View Award
PHASE I - MOTION SIMULATION EFFECTIVENESS ON COLICKY
Sweet Dreems Inc. · Department of Health and Human Services
Phase I1983$55,888
N/A
- View Award
PERCORP Enhancement for Improved Soot Modeling
SIERRA ENGINEERING, INC. · Department of Defense
Phase I2003$69,981
PERCORP is a program that accurately predicts the exhaust constituents, including soot, in liquid propellant rocket engines. It was developed by Sierra Engineering Inc. (Sierra) for the Plume Phenomenology group (PRSA)…
- View Award
PRENATAL DIAGNOSIS OF INHERITED BLOOD DISORDERS
AMERICAN LABORATORY SUPPLIES · Department of Health and Human Services
Phase I1997$99,900
During pregnancy small numbers of fetal erythrocytes enter the maternal circulation. Among these cells are nucleated erythrocytes called normoblasts. Genomic analysis of these normoblasts using specific probes by in sit…
View Award - View Award
PURPOSE OF THIS MODIFICATION IS TO EXERCISE THE I-CORP OPTION
Nomocan Pharmaceuticals LLC · Department of Health and Human Services
Phase I2023$354,959
NomoCan Pharmaceuticals is developing a first-in-class humanized monoclonal antibody, NMC-521, against a novel plasma membrane-bound variant of the protein MDM2 as a targeted treatment for cancer with fewer side effects…
- View Award
PROTOTYPE GENERALIZED INTERACTIVE MINEFIELD EVALUATION MODEL
Omni Analysis Inc · Department of Defense
Phase I1987$49,879
N/A
- View Award
PARENT-DELIVERED EDUCATION FOR CHILDHOOD ASTHMA
Iox Assessment Assoc · Department of Health and Human Services
Phase II1984$433,386
THE PROJECT WILL CONCEPTUALIZE, DEVELOP, AND VALIDATE A PARENT-DELIVERED ASSESSMENT AND INSTRUCTIONAL PROGRAM. THIS PROGRAM WILL PROMOTE THE SUCCESSFUL SELF-MANAGEMENT OF CHILDHOOD ASTHMA BY ENHANCING CHILDREN'S CAPABIL…
- View Award
POROUS MICROCARRIERS FOR GROWING CELL CULTURES
Biotech Research Laboratory · Department of Health and Human Services
Phase II1987$242,000
THE OVERALL OBJECTIVE OF THIS PROGRAM IS TO DEVELOP COST-EFFECTIVE TECHNOLOGY FOR THE SCALE-UP OF MAMMALIAN CELL CULTURE FOR THE MANUFACTURE OF PRODUCTS SUCH AS MONOCLONAL ANTIBODIES OR GENETICALLY ENGINEERED PROTEINS.…
- View Award
Pulse Pileup Recovery for Energy Dispersive Spectroscopy
4pi Analysis, Inc. · Department of Health and Human Services
Phase II1997$404,257
Quantitative energy dispersive spectroscopy (EDS) x-ray microanalysis provides important information regarding the distribution of elements within a biological sample. The low elemental concentrations in biological spec…
- View Award
Predict Near Future Bed Exit for Effective Intervention to Avoid Nighttime Falls
CDIC, Inc. · Department of Health and Human Services
Phase I2012$150,000
DESCRIPTION (provided by applicant): The proposed research will determine the feasibility of using non-invasive, unobtrusive continuous monitoring of vital signs and gross movement in bed as input to an early warning sy…
- View Award
PASSIVE CONTRAIL SUPPRESSION (C)
N.s. Gowadia, Inc. · Department of Defense
Phase I1992$49,445
LOW OBSERVABLE (LO) OPERATIONS ARE THWARTED WHEN CONTRAILS ARE FORMED. IT IS ESSENTIAL THAT MEANS BE SOUGHT TO AUTOMATICALLY DETECT AND ONCE DETECTED, ELIMINATE THIS VISUAL SIGNATURE SO THAT THE OPERATIONAL ADVANTAGE OF…
- View Award
POCKET EXPERT SYSTEM FOR ASTHMA SELF-CARE
SOFTCARE CLINICAL INFORMATICS · Department of Health and Human Services
Phase I1999$99,776
N/A
- View Award
PRODUCING NATURAL BETA-CAROTENE FOR CHEMOTHERAPEUTIC USE
MARTEK BIOSCIENCE CORPORATION · Department of Health and Human Services
Phase I1991$50,000
BETA-CAROTENE (PROVITAMIN A) HAS RECENTLY BEEN SHOWN TO BE AN EFFECTIVE CHEMOTHERAPEUTIC AGENT IN THE TREATMENT AND PREVENTION OF CANCER. MOREOVER, CAROTENES PRODUCED BIOSYNTHETICALLY (CONTAINING 9-CIS ISOMERS) APPEAR T…
- View Award
PHOTOIMMOBILIZED CATHETER COATINGS TO INHIBIT FIBROSIS
SURMODICS, INC. · Department of Health and Human Services
Phase I1997$100,000
N/A
- View Award
PASSIVE SENSORS FOR APPLICATION TO LOW OBSERVABLE AIRCRAFT
E-tek Dynamics Inc. · Department of Defense
Phase I1990$49,953
IN PHASE I, E-TEK WILL ANALYZE, DESIGN AND OPTIMIZE AN INNOVATIVE PASSIVE MAGNETIC SENSORING SYSTEM TO DETECT LOW OBSERVABLE AIRCRAFT. THIS INNOVATIVE MAGNETIC SENSORING SYSTEM PROVIDES <10 X-13 GAUSS SENSITIVITY, GREAT…
- View Award
Phase II Commercialization of Continuous Countercurrent Tangential Chromatography
SPHYNKX THERAPEUTICS, LLC · Department of Health and Human Services
Phase I2013$316,867
DESCRIPTION: Vascular leak is a hallmark of tissue injury, and results in the movement of plasma into the interstitium where immune mediators and clotting factors invade the injured tissue. Left to persist, vascular lea…
- View Award
POLYACETALS AS POLYMER THERAPEUTICS
A. P. PHARMA · Department of Health and Human Services
Phase I2004$99,085
DESCRIPTION (provided by applicant): The success of cancer chemotherapy is limited by the concentration of chemotherapeutic agents that can be accumulated in the tumor without exceeding limits imposed by systemic toxici…
- View Award
PORTABLE FLOW MEASUREMENT SYSTEM
Yellowstone Environmental · Department of Agriculture
Phase I1992$50,000
N/A
- View Award
Pedestrain Exposure Measurement Technology Development
CALSPAN CORPORATION · Department of Transportation
Phase I2008$98,860
Calspan Corporation, located in Buffalo, NY is proposing the research and development of the technology and methodolgy that can be used to accurately measure pedestrian exposure. Existing technologies/methodologies will…
- View Award
PHYSIOLOGICAL METHOD FOR THE GROWTH OF TISSUE IN VITRO
Marrow Tech Inc · Department of Health and Human Services
Phase I1989$38,730
A THREE-DIMENSIONAL SYSTEM FOR THE GROWTH OF HUMAN TISSUES IN VITRO HAS BEEN DEVELOPED AT MARROW-TECH, INC. IN THIS PHYSIOLOGICAL METHOD, STROMAL CELLS ARE ESTABLISHED ON A SUPPORT MATRIX AND ACT TO PROVIDE A FOUNDATION…
- View Award
Pills & Patient Behavior Smarter Experience Tracking
LIFETECHNIQUES, INC. · Department of Health and Human Services
Phase I2005$198,864
DESCRIPTION (provided by applicant): Medication noncompliance is highly problematic in pharmaceutical studies. Without direct observation of pilltaking patterns, investigators - much like clinicians-are often misled by…